{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-039733","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.429914+00:00","generated_at":"2026-05-22T17:51:17.309403+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"INmune Bio schedules Q1 2025 earnings call for May 8; no results released yet","bullets":["Press release dated May 5, 2025 announces conference call on May 8, 2025 at 4:30 p.m. ET.","Call will discuss Q1 2025 financial results and provide a corporate update.","Dial-in: 1-800-267-6316 (US) or +1-203-518-9783 (international); Conference ID: INMUNE.","Webcast and replay available; transcript expected within 24 hours."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-039733","json":"https://secwatch.observer/filing/0001213900-25-039733.json","markdown":"https://secwatch.observer/filing/0001213900-25-039733.md","text":"https://secwatch.observer/filing/0001213900-25-039733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025039733/0001213900-25-039733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025039733/ea0240883-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T17:51:17.309403+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}